Matt Carthy (Cavan-Monaghan, Sinn Fein) | Oireachtas source

The question is not necessarily product specific. It is about antimicrobial resistance legislation. I know it will keep coming at European level because the Commission is under pressure from some member states and from some elements within the European Parliament to continue to review and strengthen any provisions that are in place. I am saying that the starting point should be that we would support measures that tackle antimicrobial resistance but that we also need to be cognisant of the potential impacts it would have. The best way to do that is to ensure we have ongoing engagement with all the stakeholders that can be identified prior to Ireland adopting a position at a European level.